Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive phase III trial results reported for phosphate binder

Jan. 9, 1997

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Anti-TGF-beta MAbs from Celtrix

Dec. 31, 1996

LJP licenses rights to drug for lupus

Dec. 30, 1996

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

Licensees sought for PKD1 gene and mutations

Dec. 17, 1996

More terazosin clinical data reported

Dec. 17, 1996

New diuretics reported by Pharmacia & Upjohn

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...